Red Blood Cell Transfusion in the Intensive Care Unit.

Raasveld, Senta Jorinde; de Bruin, Sanne; Reuland, Merijn C; van den Oord, Claudia; Schenk, Jimmy; Aubron, Cécile; Bakker, Jan; Cecconi, Maurizio; Feldheiser, Aarne; Meier, Jens; Müller, Marcella C A; Scheeren, Thomas W L; McQuilten, Zoe; Flint, Andrew; Hamid, Tarikul; Piagnerelli, Michaël; Tomic Mahecic, Tina; Benes, Jan; Russell, Lene; Aguirre-Bermeo, Hernan; ... (2023). Red Blood Cell Transfusion in the Intensive Care Unit. JAMA : the journal of the American Medical Association, 330(19), pp. 1852-1861. American Medical Association 10.1001/jama.2023.20737

Text jama_raasveld_2023_oi_230121_1696973932.3.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (347kB)

IMPORTANCE

Red blood cell (RBC) transfusion is common among patients admitted to the intensive care unit (ICU). Despite multiple randomized clinical trials of hemoglobin (Hb) thresholds for transfusion, little is known about how these thresholds are incorporated into current practice.

OBJECTIVE

To evaluate and describe ICU RBC transfusion practices worldwide.

DESIGN, SETTING, AND PARTICIPANTS

International, prospective, cohort study that involved 3643 adult patients from 233 ICUs in 30 countries on 6 continents from March 2019 to October 2022 with data collection in prespecified weeks.

EXPOSURE

ICU stay.

MAIN OUTCOMES AND MEASURES

The primary outcome was the occurrence of RBC transfusion during ICU stay. Additional outcomes included the indication(s) for RBC transfusion (consisting of clinical reasons and physiological triggers), the stated Hb threshold and actual measured Hb values before and after an RBC transfusion, and the number of units transfused.

RESULTS

Among 3908 potentially eligible patients, 3643 were included across 233 ICUs (median of 11 patients per ICU [IQR, 5-20]) in 30 countries on 6 continents. Among the participants, the mean (SD) age was 61 (16) years, 62% were male (2267/3643), and the median Sequential Organ Failure Assessment score was 3.2 (IQR, 1.5-6.0). A total of 894 patients (25%) received 1 or more RBC transfusions during their ICU stay, with a median total of 2 units per patient (IQR, 1-4). The proportion of patients who received a transfusion ranged from 0% to 100% across centers, from 0% to 80% across countries, and from 19% to 45% across continents. Among the patients who received a transfusion, a total of 1727 RBC transfusions were administered, wherein the most common clinical indications were low Hb value (n = 1412 [81.8%]; mean [SD] lowest Hb before transfusion, 7.4 [1.2] g/dL), active bleeding (n = 479; 27.7%), and hemodynamic instability (n = 406 [23.5%]). Among the events with a stated physiological trigger, the most frequently stated triggers were hypotension (n = 728 [42.2%]), tachycardia (n = 474 [27.4%]), and increased lactate levels (n = 308 [17.8%]). The median lowest Hb level on days with an RBC transfusion ranged from 5.2 g/dL to 13.1 g/dL across centers, from 5.3 g/dL to 9.1 g/dL across countries, and from 7.2 g/dL to 8.7 g/dL across continents. Approximately 84% of ICUs administered transfusions to patients at a median Hb level greater than 7 g/dL.

CONCLUSIONS AND RELEVANCE

RBC transfusion was common in patients admitted to ICUs worldwide between 2019 and 2022, with high variability across centers in transfusion practices.

Interest & Impact

Downloads

0 since deposited on 13 Oct 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item